Riskpilot← Back to searchSign inGet full accessEngborg Medical AB
ABActiveOrg 5591741037Kråkeberg Persö 1Technical testing and analysis · NACE 7120Est. 20180 employees
Revenue 2025
SEK 113K
-2% vs 2024
EBITDA margin
76.3%
-8% vs 2024
Equity ratio
88.8%
Financial strength
Net profit 2025
SEK 69K
-6% vs 2024
| Revenue | SEK 113K | -2% |
| EBITDA | SEK 86K | -8% |
| Net profit | SEK 69K | -6% |
| Total assets | SEK 385K | +0% |
| Equity | SEK 342K | +25% |
| Employees | 0 | — |
Legal name
Engborg Medical AB
Org number
5591741037
Legal form
Aktiebolag
NACE code
7120 · Technical testing and analysis
Founded
4 oktober 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-07-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva läkartjänster, rådgivning, utbildning och konsultverksamhet rörande sjukvård och friskvård samt annan därmed förenlig verksamhet, så som produktion och distribution av undervisningsmaterial. Bolaget kommer även utföra handel med värdepapper, äga och förvalta fast och lös egendom samt bedriva därmed förenlig verksamhet.
Address
Kråkeberg Persö 1
Email
jonathan.engborg@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 231 | 42 | 42 | 116 | 113 |
| Staff expenses | — | — | −0 | −1 | −0 |
| EBITDA | 214 | 15 | 34 | 93 | 86 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 214 | 15 | 34 | 93 | 86 |
| Net financials | — | — | −1 | −0 | 1 |
| Profit before tax | 214 | 15 | 34 | 93 | 87 |
| Tax | −46 | −2 | −7 | −19 | −18 |
| Net profit | 168 | 13 | 27 | 74 | 69 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 292 | 280 | 283 | 384 | 385 |
| Equity | 239 | 252 | 278 | 272 | 342 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 53 | 29 | 5 | 112 | 43 |
| Total debt | 53 | 29 | 5 | 112 | 43 |
EBITDA margin
76.3%
This company
15.8%
Market median
+383% vs market
20212025
Equity ratio
88.8%
This company
38.2%
Market median
+132% vs market
20212025
Return on equity
20.3%
This company
18.4%
Market median
+10% vs market
20212025
Net profit margin
61.4%
This company
8.1%
Market median
+658% vs market
20212025
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
20212025
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-08-01 – 2025-07-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-08-01 – 2024-07-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-08-01 – 2023-07-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-08-01 – 2022-07-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-08-01 – 2021-07-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Engborg Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| David Jonathan Engborg | Board of Directors | 0 companies |
| Sara Ingrid Elisabeth Sönnermyr | Board of Directors | 0 companies |